Sugammadex facilitates early recovery after surgery even in the absence of neuromuscular monitoring in patients undergoing laryngeal microsurgery: a single-center retrospective study

Table 3 Postoperative adverse events in PACU

Variables	Group S (n = 68)	Group P (n = 67)	P-value
PONV required to use rescue antiemetics (n)	1	None	0.994
Hypertension events (%)	3.0	2.9	0.977
Hypotension events (%)	4.1	6.4	0.17
Tachycardia events (%)	8.0*	17.3	≤0.001
Bradycardia events (%)	7.8	10.7	0.156
Incomplete reversal case with hypoxia (n)	None	1	0.994

The patient data are presented as number of patients (n) or incidence of haemodynamic events (%). Group S: patients who received sugammadex as a reversal agent. Group P: patients who received pyridostigmine as a reversal agent
PACU post-anaesthesia care unit, PONV Postoperative nausea and vomiting
*P < 0.05 vs. group P

ISSN: 1471-2253